Correlation Between Eterna Therapeutics and MiMedx

Can any of the company-specific risk be diversified away by investing in both Eterna Therapeutics and MiMedx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eterna Therapeutics and MiMedx into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eterna Therapeutics and MiMedx Group, you can compare the effects of market volatilities on Eterna Therapeutics and MiMedx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eterna Therapeutics with a short position of MiMedx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eterna Therapeutics and MiMedx.

Diversification Opportunities for Eterna Therapeutics and MiMedx

-0.85

Correlation Coefficient

Eterna Therapeutics  MiMedx

Pay attention - limited upside

The 3 months correlation between Eterna and MiMedx is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and MiMedx Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MiMedx Group and Eterna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eterna Therapeutics are associated (or correlated) with MiMedx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MiMedx Group has no effect on the direction of Eterna Therapeutics i.e., Eterna Therapeutics and MiMedx go up and down completely randomly.

Pair Corralation between Eterna Therapeutics and MiMedx

Given the investment horizon of 90 days Eterna Therapeutics is expected to under-perform the MiMedx. In addition to that, Eterna Therapeutics is 5.11 times more volatile than MiMedx Group. It trades about -0.47 of its total potential returns per unit of risk. MiMedx Group is currently generating about 0.01 per unit of volatility. If you would invest  914.00  in MiMedx Group on September 18, 2024 and sell it today you would earn a total of  2.00  from holding MiMedx Group or generate 0.22% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	95.24%
Values	Daily Returns

Eterna Therapeutics  vs.  MiMedx Group

Eterna Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eterna Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

MiMedx Group

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in MiMedx Group are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, MiMedx reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Eterna Therapeutics and MiMedx

The main advantage of trading using opposite Eterna Therapeutics and MiMedx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eterna Therapeutics position performs unexpectedly, MiMedx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MiMedx will offset losses from the drop in MiMedx's long position.

The idea behind Eterna Therapeutics and MiMedx Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.